Our Faculty

Home » Our Faculty » Regina M. Santella

Regina M. Santella

Professor of Environmental Health Sciences

and:
Co-leader Cancer Epidemiology Program and Director Biomarkers Shared Resource, Herbert Irving Comprehensive Cancer Center
Director, Center for Environmental Health in Northern Manhattan
Biography:
Dr. Regina Santella's research involves the use of biomarkers for the detection of human exposure to environmental and occupational carcinogens in molecular epidemiology studies to identify causative factors, susceptible populations, and preventive interventions. Her work has allowed the determination of exposure to carcinogens by the measurement of their binding to DNA with highly specific and sensitive immunoassays using monoclonal and polyclonal antibodies that her laboratory has developed. These studies have demonstrated higher levels of DNA damage in those with environmental or occupational exposures and in subjects with breast, lung, and liver cancer compared to controls. The role of genetic susceptibility in cancer risk is also being investigated. Current studies seek to understand the role of environmental/lifestyle factors on epigenetic changes and how they impact cancer risk as well as whether epigenetic changes in DNA methylation and microRNAs can be used for early diagnosis of cancer.   View Faculty CV here (PDF).
Education & Training:

PhD, City University of New York, 1976

MS, University of Massachusetts, 1971

BS, Brooklyn College, 1969

Affiliation(s):

University Affiliations:

Additional Affiliations:

  • Member, American Association for Cancer Research
  • Member, Society of Toxicology
  • Member, American Chemical Society
  • Member, Environmental Mutagen Society
  • Member, Sigma Xi
  • Member, Harvey Society
Selected
Global
Activities:
    Biological Markers of Aflatoxin Exposure
    Dr. Santella is working on a case-control study of hepatocellular cancer nested in a cancer screening cohort of 25,000 subjects. Biomarkers of exposure to environmental carcinogens, hepatitis virus infection, and epigenetic changes are being measured.

    Countries: Taiwan

Selected Publications:
    Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, Yu MW, Chen CJ, Santella RM  "Genome-wide DNA methylation profiles in hepatocellular carcinoma" Hepatology 55 1799-1808 2012

    Lumey LH, Terry MB, Delgado-Cruzata L, Liao Y, Wang Q, Susser E, McKeague I, Santella RM.  "Adult DNA methylation in relation to prenatal nutrition" Int J Epidemiol. 41 116-123 2012

    Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, Xu X, Bradshaw PT, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM. "Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients" Breast Cancer Res Treat. 131 197-205 2012

    Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, and Santella RM.  "DNA methylation in white blood cells: Association with risk factors in epidemiologic studies" Epigenetics 6 828-837 2011

    Hoque A., Ambrosone C.B., Till, C., Goodman, P.J., Tangen, C., Kristal, A., Lucia, S., Wang, Q., Kappil, M., Thompson, I., Hsing, A.W., Parnes, H., Lippman, S.M., Santella, R.M. "Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial" Hoque A., Ambrosone C.B., Till, C., Goodman, P.J., Tangen, C., Kristal, A., Lucia, S., Wang, Q., Kappil, M., Thompson, I., Hsing, A.W., Parnes, H., Lippman, S.M., Santella, R.M. Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. Cancer Prevention Research 3, 478?483, 2010 3 478-483 2010

    Zipprich, J., Terry, M.B., Liao, Y., Agrawal, M., Gurvich, I., Senie, R., and Santella, R.M.  "Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry" Cancer Research 69 2966-2972 2009

    Yazici, H., Terry, M.B., Cho, Y.H., Senie, R.T., Liao, Y., Andrulis, I., and Santella, R.M. "Aberrant methylation of RASSF1A in plasma DNA prior to breast cancer diagnosis in the Breast Cancer Family Registry" Epidemiology, Biomarkers & Prevention 19 2723-2725 2009

    Zhang, Y-J., Wu, H-C., Shen, J., Ahsan, H., Tsai, W.Y., Yang, H.I., Wang, L.Y., Chen, S.Y., Chen, C.J. and Santella, R.M.  "Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA." Clinical Cancer Research  13 2378-2384 2007

    Kennedy, D.O., Agrawal, M., Shen, J., Terry, M.B., Zhang, F.F., Senie, R.T., Motykiewicz, G., and Santella, R.M. "DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer" Journal of the National Cancer Institute 97 127-132 2005

-top-

Contact Information

Office/Address:

630 West 168th St Room 16-410

New York, NY 10032

Website Address:

Homepage URL

Phone:

212-305-1996

Fax:

212-305-5328

E-mail:

rps1@columbia.edu